Pharmacology
Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice Lebson, L. et al. J. Neurosci. 30, 9651–9658 (2010)
Lebson et al. have shown that CD11b+ bone marrow cells not only migrate to amyloid plaques in transgenic Alzheimer disease mice, but also, when expressing a genetically engineered form of neprilysin, can inhibit further amyloid deposition. The researchers argue that the capability of such cells to enter the CNS and home in on sites of injury might be harnessed in gene therapy strategies for a range of CNS diseases.
Parkinson disease
In patients with Parkinson disease (PD), olfactory dysfunction can be apparent several years before motor symptom onset. Diffusion tensor imaging in a small group of patients in the early stages of PD shows, for the first time, that the degree of olfactory dysfunction correlates positively with the extent of microstructural white matter reduction in the olfactory system.
Stroke
Few options are available to combat hypoxic–ischemic injury in neonates. Zhang et al. have now demonstrated that supplementation of the diet of pregnant rats with omega-3 polyunsaturated fatty acids confers a neuroprotective effect against hypoxic–ischemic injury to their neonates. The data indicate that this effect is achieved, in part, by suppression of an inflammatory response mediated by microglia.
Parkinson disease
Li et al. have shown that among individuals with Parkinson disease (PD), those with depression have greater microstructural changes in the white matter of the mediodorsal thalamus—as revealed on fractional ansiotropy maps from diffusion tensor imaging—than those without depression. The researchers conclude that this brain region might have an important role in the development of depression in PD.
Rights and permissions
About this article
Cite this article
In Brief. Nat Rev Neurol 6, 526 (2010). https://doi.org/10.1038/nrneurol.2010.138
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.138